Non-clinical and clinical development of similar biological medicinal products containing low-molecular-weight heparins

Current effective version

PDF iconAdopted guideline - Revision 1

Reference numberEMEA/CHMP/BMWP/118264/2007 Rev. 1
Effective from01/06/2017
KeywordsLow molecular weight heparins, low molecular mass heparins, similar biological medicinal products, biosimilar, comparability, quality, non-clinical studies, clinical studies, extrapolation
DescriptionThis document lays down the non-clinical and clinical requirements for low molecular weight heparins (LMWHs, low molecular mass heparins, LMMH) containing medicinal products claiming to be similar to another one already marketed.

Document history

Revision 1

Current version

PDF iconAdopted guideline

PDF iconDraft guideline

PDF iconConcept paper

Published: 24/11/2016

Effective from: 01/06/2017

Published: 31/01/2013

Published: 27/07/2011

First version

PDF iconAdopted guideline

PDF iconOverview of comments

PDF iconDraft guideline

PDF iconConcept paper

In operation: 01/10/2009 - 01/06/2017

Published: 17/11/2009

Published: 24/04/2008

Published: 24/01/2007

Related content

How useful was this page?

Add your rating